A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Dofetilide (Tikosyn)

Dofetilide stabilizes heart rhythm in patients with irregular heartbeat.

First FDA approval1999-10-01
Generic availableYes · 8 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$96.7M in CY2024 Part D spend515K claims · 144K beneficiaries · 329 plans surveyed

Lowest NADAC
$0.182/unit
20 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.188
Across all dosage forms in distribution.
Highest NADAC
$0.197
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema11 entries indexed · 4 visible
What is Dofetilide used for?

Dofetilide stabilizes heart rhythm in patients with irregular heartbeat.

Is there a generic for Dofetilide?

Yes. 24 ANDAs filed at FDA, 8 generic manufacturers currently shipping.

How much does my plan pay for Dofetilide?

Across 329 Part D plans, Dofetilide averages $0.188/unit (NADAC). Lowest available: $0.182/unit. Highest in distribution: $0.197/unit.

Is Dofetilide on the FDA shortage list?

No. Dofetilide is not currently on the FDA Drug Shortage Database.

7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Antiarrhythmic6 alternatives in D1
01
Amiodarone
Brand: Nexterone
$0.121Lowest NADAC
15Generic mfrs
$116.4MCY24 Part D spend
Compare →
02
Dronedarone
Brand: Multaq
$13.19Lowest NADAC
1Generic mfrs
$626.9MCY24 Part D spend
Compare →
03
Flecainide
Antiarrhythmic
$0.112Lowest NADAC
7Generic mfrs
$77.9MCY24 Part D spend
Compare →
04
Lidocaine Hydrochloride
Brand: AKTEN
Lowest NADAC
25Generic mfrs
CY24 Part D spend
Compare →
05
Mexiletine
Antiarrhythmic
$0.254Lowest NADAC
8Generic mfrs
$14.2MCY24 Part D spend
Compare →
06
Procainamide
Antiarrhythmic
Lowest NADAC
5Generic mfrs
CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.